Aging drives the accumulation of senescent cells (SnCs) including stem/progenitor cells in bone marrow, which contributes to aging-related bone degenerative pathologies. Local elimination of SnCs has been shown as potential treatment for degenera- 
| INTRODUCTION
Aging is the main causative pathological factor for bone degenerative diseases and functional deficits in humans (Finch, 2010; Stenderup, Justesen, Clausen, & Kassem, 2003) . During aging, bone homeostasis is interrupted with the chaos of the marrow microenvironment, including a disrupted HSC niche (Mendelson & Frenette, 2014) , decreased vessel formation and abnormal inflammation factor release (Lepperdinger, 2011) . As a result, increased cellular senescence in bone marrow can be induced by cellular damage or environment changes. It is reported that senescent cells (SnCs) accumulate in bone marrow with aging (Farr et al., 2017) and contribute to age-related pathologies through their secretion of factors contributing to the senescence-associated secretory phenotype (SASP) (Campisi, 2000 (Campisi, , 2013 Nelson et al., 2012) .
SnCs exhibit essentially stable cell cycle arrest through the actions of tumour suppressors such as p16 INK4a , p53, p21 CIP1 (Campisi, 2005; Serrano, Lin, McCurrach, Beach, & Lowe, 1997) and also include increased lysosomal b-galactosidase activity, robust secretion of inflammatory cytokines/chemokines, and nuclear foci containing DNA damage response proteins or distinctive heterochromatin.
Although cell senescence has been well studied in recent decades, the mechanisms and local treatment targets for SnCs-induced bone degenerative disease are not well understood.
Mesenchymal stromal cells (MSCs), including mesenchymal stem/ progenitor cells (MSPCs), play an essential role in bone metabolism
and HSC maintenance (Kfoury & Scadden, 2015) . However, the proliferation and function of MSCs are largely impaired during aging (Alt et al., 2012; Fehrer, Laschober, & Lepperdinger, 2006) . Bonyadi et al. (2003) reported that MSC "deficiencies" in terms of either number or cellular function could be the driving force of musculoskeletal diseases, and other studies also mentioned the diseases remote from the musculoskeletal environment, including osteoarthritis and diabetes due to MSC "deficiencies" (Jeon et al., 2017; Zang et al., 2017) . Likewise, MSC senescence during aging markedly impairs the HSC niche (Iyer, Brooks, Gumbleton, & Kerr, 2015) , decreases osteoblast numbers and disrupts epithelial-mesenchymal transition (Zhou et al., 2008) . LepR + cells in bone marrow were a major source of CFU-F-forming MSPCs in adult and formed bone, cartilage and adipocytes in culture and upon transplantation (Zhou, Yue, Murphy, Peyer, & Morrison, 2014) . Additionally, LepR + cells are essential for maintaining the HSC niche through secreting Scf (Asada et al., 2017) . However, little is known about whether LepR + cells are senescent and dysfunctional during aging. Increasing in vivo evidence suggests that cellular senescence is modulated by several post-translational modifications of histones, including methylation, acetylation, phosphorylation and ubiquitination. For instance, Ezh2 is the functional enzymatic component of polycomb repressive complex 2 (PRC2), which has histone methyltransferase activity and primarily trimethylates histone H3 on lysine 27 (Margueron & Reinberg, 2011) . Ezh2 has been shown to be recruited to and methylate the Ink4A locus in human BMSCs and to be involved in inhibiting senescence by the Twist-1 transcription factor (Cakouros et al., 2012) . Li et al. (2017) also showed that MSC senescence could be epigenetically modulated by EZH2-H3K27me3 in late puberty. However, whether aging-induced MSC senescence and microenvironment disruption could be pharmacologically and epigenetically modulated still need to be determined.
Tetramethylpyrazine (TMP), the bioactive component extracted from Ligusticum wallichii Franchat (Chuanxiong) which is widely used for the treatment of ischaemic stroke, cerebral infarction and degenerative diseases of the central nervous system (Chen et al., 2017; Sun et al., 2012) , has been reported to have anti-inflammatory and anticancer effects in certain cell types (Chen et al., 2014; Gong, Ivanov, Davidson, & Hei, 2015; Yu et al., 2015) . We previously showed that TMP could protect MSCs from glucocorticoid-induced apoptosis and be used for the prevention and treatment of glucocorticoidinduced osteoporosis (GIOP) . In this study, we aimed to investigate the local effect of TMP on the bone marrow of aging mice and to determine whether the senescent phenotype of (Campisi, 2005) and disrupt tissue structure and function (Coppe et al., 2008; Rodier & Campisi, 2011) . Cells exhibiting a senescent phenotype display essentially stable cell cycle arrest through the actions of tumour suppressors, such as p16
INK4a
, p53, p21 CIP1 or others (Campisi, 2005; Serrano et al., 1997) . We first investigate the local effect of TMP on bone marrow cells of aging mice. We screened the dosage of TMP injected in bone marrow cavity of either 4-or 20-month-old male mice, and 10 lg/kg was chosen for the following in vivo experiment because of the high efficiency of its antisenescence effect ( Figure S1 ). Additionally, we have showed in previous studies that TMP has no toxic effect on live cells . We conducted exploratory senescence- Figure S2C ).
Moreover, co-immunostaining of p16 with BrdU showed that the number of proliferative cells significantly decreased in aging mice and that TMP further ameliorated this phenotype ( Figure S2D -F), which indicates that the majority of senescent cells suffered from a high DNA damage burden and markedly lost their proliferation ability and function, and TMP rescued the phenotype via inhibiting cell senescence and promoting proliferation. As a result, TMP significantly increased the trabecular bone microarchitecture (Figure 1g, i, j, k) , while the cortical bone was not markedly affected (Figure 1h, l, m) . Moreover, TMP significantly decreased osteoclast numbers in trabecular bone ( Figure S3A ) and the endosteal bone surface ( Figure S3B ) but not the periosteal bone surface ( Figure S3C) and also decreased the circulating CTX levels in 20-month-old mice ( Figure S3D ). Interestingly, we isolated osteoclasts from 4-and 20- Data are represented as mean AE SEM. MP, metaphysis. DP, diaphysis. *p < .05, **p < .01, NS, no significance as determined by two-tailed Student's t tests Fuchs, 2016; Adam et al., 2015) . The polycomb group (PcG) protein enhancer of zeste homologue 2 (Ezh2), which functions as a lysine N-methyltransferase, mediates the repression of gene transcription through the trimethylation of histone H3 in lysine 27 (H3K27me3) to modulate progenitor cell senescence (Wei et al., 2011) . We found that the mRNA and protein levels of Ezh2 were markedly decreased ; however, the degree of change in enrichment was not significant (Figure 3e ).
As a result, TMP significantly decreased the mRNA and protein levels of p16 and p21, while it increased the level of Ki67 (Figure 3f-i) . However, knock-down of Ezh2 markedly blocked the effect of TMP on p16, p21 and Ki67 (Figure 3f- It is reported that LepR + MSPCs is essential in maintaining the HSC niche (Zhou et al., 2014) . To gain more insight into the regulatory effect of TMP on the bone marrow microenvironment and SnCs and inhibition of a certain SASP improves cardiovascular function (Roos et al., 2016) , enhances insulin sensitivity (Xu, Palmer et al., 2015) and reduces frailty; (Xu, Tchkonia et al., 2015) . Several recent studies have targeted local elimination of SnCs as a treatment for bone degenerative diseases, such as osteoarthritis and osteoporosis (Farr et al., 2017; Jeon et al., 2017) . We previously determined that TMP could protect MSCs from glucocorticoid-induced apoptosis and could be used for the prevention and treatment of GIOP .
In this study, we further observed the local effect of TMP on the bone marrow of aging mice and, interestingly, found that the local delivery Bone marrow homeostasis is maintained in balance with the precise adjustment of various components, including HSC maintenance, the blood supply, anti-inflammatory factors and proper metabolic responses. During aging, the bone marrow microenvironment is disrupted with multiple impaired physiologic processes. Adams et al.
defined the H-type vessel, which exhibits distinct molecular properties and is strongly positive for the endothelial cell surface markers CD31 and Emcn (CD31 hi Emcn hi ) as assessed by immunofluorescence staining and which is diminished during aging .
Additionally, the H-type vessel modulates local microenvironments in the skeletal system, plays crucial roles in osteogenesis and provides niches for haematopoietic stem cells (Cui et al., 2016; Ramasamy, Kusumbe, Wang, & Adams, 2014 but also improved the whole marrow homeostasis and microenvironment, which will further ameliorate cellular senescence in aging bone marrow.
Of note, several studies have demonstrated that Ezh2 is an essential regulator of bone formation through modulating the osteogenic differentiation of MSCs (Chen et al., 2016; Hemming et al., 2016 Hemming et al., , 2017 . Additionally, Li et al. (2017) found that Ezh2 also modulated the programmed senescence of MSCs during late puberty. He knocked out Ezh2 f/f in Nestin-cre ER and found that deletion of Ezh2 (Ezh2 Medical University in Xi'an, China, and were housed under specific pathogen-free conditions (20°C, 12-hr light/12-hr dark cycles and 50%-55% humidity) with free access to food and water. All mice from either 4-month or 20-month were randomly divided into different concentrations of TMP-treated groups (0, 1, 10, 100, 1000 lg/ kg) with eight mice per group. The mice were injected intramedullary with TMP or sesame oil (as a vehicle control), three times/week for 8 weeks. There was no significant difference in total body weight with same age among all the groups before the mice were sacrificed.
For Brdu administration, mice were given an intraperitoneal injection of 100 mg BrdU per kg body mass in Dulbecco's phosphate-buffered saline (DPBS; Gibco) and were maintained on 1 mg/ ml BrdU in the drinking water for 10 days before being sacrificed.
Amber bottles containing BrdU water were changed every 1-3 days.
For intramedullary injection, TMP was delivered into the bone marrow cavity of mice from the medial side of the patellar tendon using 0.5-mL syringes with 27-gauge needles for 8 weeks as indicated above.
All experimental procedures in animals were approved by the de-cross-linking, the precipitated DNA was purified using a QIAquick PCR purification kit (Qiagen).
| ChIP-qPCR
ChIP-qPCR was performed using SYBR Green PCR Master Mix and 7900 HT Fast Real-Time PCR System (Applied Biosystems Corp., Foster City, CA, USA). Primers for p16, p21, P27 and P15 were used (see Table S1 for primer sequences). Absolute quantification was performed and enrichment expressed as a fraction of the whole-cell extract control.
| Preparing total RNA for quantitative reverse transcription PCR (qRT-PCR)
Cells were sorted directly into Trizol. Total RNA was extracted according to the manufacturer's instructions (Invitrogen). Total RNA was subjected to reverse transcription and then qRT-PCR using SYBR Green on a LightCycler 480 (Roche). Primers used in this study were listed in Table S2 for primer sequences.
For methods related to microcomputed tomography assessment, immunocytochemistry, immunofluorescence, cell culture, tube formation assay, Western blot and ELISA, see the Appendix S1.
| Statistics and reproducibility
Data are presented as means AE standard errors of the mean.
Unpaired, two-tailed Student's t tests were used for comparisons between two groups. For multiple comparisons, one-way analysis of variance (ANOVA) with Bonferroni post hoc test was applied. All data were normally distributed and had similar variation between groups. Statistical analysis was performed using SAS version 9.3 software (SAS Institute, Inc., Cary, NC, USA). p < .05 was deemed significant. 
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